Gpi and Umana test T1 system during the Giro d’Italia 2020
Nanotechnology meets sport: the aim is to monitor vital parameters during physical activity
Nanotechnology meets sport: the aim is to monitor vital parameters during physical activity
Umana Medical’s “nanotechnological” patch is being tested within the area of sports medicine. Umana Medical is the Malta based company of Gruppo Gpi, a company that produces equipment which monitors vital parameters in a non-invasive manner. Some professional cyclists which have participated in the Giro d’Italia tried out the product, based on research and development by Maltese technologists, to monitor the physiological parameters during periods of intense physical activity. Gpi is eyeing the sports sector as one of potential development in the future.
Video webacast, Tuesday 31 March 2026 – 11:30 CET
Revenue of € 546,2 million (+7%), two-figure growth abroad (+17,6%)
€27 million in new contracts signed in the last quarter of 2025